Vorinostat in combination with gemcitabine plus platinum in patients with advanced non-small-cell lung cancer: A phase I, dose-escalation study

被引：3
|
作者：
Misset, J.
Tredaniel, J.
Descourt, R.
Morot-Sibilot, D.
Zalcman, G.
Gachard, E.
Garcia-Vargas, J.
Rizvi, S.
Reiser, D.
Roben, L.
机构：
[1] Hop St Louis, Paris, France
[2] Inst Cancerol & Hematol, Brest, France
[3] DMAS Pneumol Oncol Thorac, Grenoble, France
[4] CHU Caen, F-14000 Caen, France
[5] MSD, Paris, France
[6] Merck Res Labs, Upper Gwynedd, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.14601
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14601
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Combination chemotherapy with carboplatin, docetaxel, and gemcitabine in advanced non-small-cell lung cancer: A phase II study
    Pectasides, D
    Aspropotamitis, A
    Halikia, A
    Visvikis, A
    Antoniou, F
    Kalantaridou, A
    Karvounis, N
    Batzios, S
    Athanassiou, A
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) : 3816 - 3821
  • [42] Triplet chemotherapy combination with gemcitabine, cisplatin and ifosfamide in patients with advanced non-small-cell lung cancer - Phase II study
    Mohedano, NM
    Rovira, PS
    Barriuso, AL
    Morales, MF
    Magan, BM
    Morago, AJ
    Quintela, IP
    Garcia, RD
    Flores, EF
    Moreno, MAM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : 363 - 365
  • [43] Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study
    Gridelli, C.
    Morgillo, F.
    Favaretto, A.
    de Marinis, F.
    Chella, A.
    Cerea, G.
    Mattioli, R.
    Tortora, G.
    Rossi, A.
    Fasano, M.
    Pasello, G.
    Ricciardi, S.
    Maione, P.
    Di Maio, M.
    Ciardiello, F.
    ANNALS OF ONCOLOGY, 2011, 22 (07) : 1528 - 1534
  • [44] Vorinostat, a Histone Deacetylase Inhibitor, in Combination with Thoracic Radiotherapy in Advanced Non-small Cell Lung Cancer: A Dose Escalation Study
    Decker, R. H.
    Gettinger, S. N.
    Glazer, P. M.
    Wilson, L. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S574 - S575
  • [45] VORINOSTAT, A HISTONE DEACETYLASE INHIBITOR, IN COMBINATION WITH THORACIC RADIOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER: A DOSE ESCALATION STUDY
    Decker, Roy H.
    Gettinger, Scott N.
    Glazer, Peter M.
    Wilson, Lynn D.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1550 - S1551
  • [46] Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors
    Sandrine Aspeslagh
    Kunwar Shailubhai
    Rastilav Bahleda
    Anas Gazzah
    Andréa Varga
    Antoine Hollebecque
    Christophe Massard
    Anna Spreafico
    Michele Reni
    Jean-Charles Soria
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 1257 - 1265
  • [47] Activity of the combination of high-dose epirubicin with gemcitabine in advanced non-small-cell lung cancer
    Van Putten, JWG
    LUNG CANCER, 2001, 34 : S61 - S64
  • [48] A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer
    Doebele, R. C.
    Conkling, P.
    Traynor, A. M.
    Otterson, G. A.
    Zhao, Y.
    Wind, S.
    Stopfer, P.
    Kaiser, R.
    Camidge, D. R.
    ANNALS OF ONCOLOGY, 2012, 23 (08) : 2094 - 2102
  • [49] Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors
    Aspeslagh, Sandrine
    Shailubhai, Kunwar
    Bahleda, Rastilav
    Gazzah, Anas
    Varga, Andrea
    Hollebecque, Antoine
    Massard, Christophe
    Spreafico, Anna
    Reni, Michele
    Soria, Jean-Charles
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (06) : 1257 - 1265
  • [50] Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer
    J. Feliu
    G. Martín
    C. Madroñal
    A. Rodríguez-Jaráiz
    J. Castro
    A Rodríguez
    T. Checa
    M. Bolaño
    E. Casado
    M. González-Barón
    Cancer Chemotherapy and Pharmacology, 2003, 52 : 247 - 252
12345